Manhattan Research Releases Latest Study Focused on How Nurses Use the Internet and Technology

Manhattan ResearchPharmaceutical and healthcare market research company Manhattan Research releases Taking the Pulse® Nurses v10.0, the latest iteration of its study focused on how nurses use digital resources, handheld devices, and other technologies in the professional setting. The market research and advisory service is based on in-depth interviews with over 1,000 U.S. nurses and physician assistants (PAs). Broad nurse market research can be segmented to provide insights for more than twenty specialist groups, including oncology, diabetes, and cardiology.

"With growing pressure to maximize prescription drug sales, marketers are increasingly looking to leverage highly influential touch points in the healthcare system beyond physicians, including nurses, payers, and pharmacists," said Monique Levy, Senior Director of Research at Manhattan Research. "Nurses represent a particularly strong opportunity for marketers - especially from a competitive standpoint - because their Internet and digital media adoption is highly advanced, but only a handful of brands have invested in the channel to date."

Key topics covered in the research include:

  • Technology and Internet Use for Professional Purposes: Technology and device ownership, websites visited during appointments, search engines, wikis, social networking websites, HCP online communities, newsletters, blogs, podcasts, attitudes toward Internet usage
  • Channel Mix: Sources used for professional information, including medical references, journals, and conferences
  • Email Use & Opportunity: Email usage and patient messaging/communication
  • Patient Interaction & Education: Source of patient education materials, websites recommended, influence on treatment decisions
  • Handheld Devices: Frequency, professional functions, clinical references, preferred points of access
  • Practice Technology: Electronic prescribing, EMR use and activities
  • Continuing Education: Current and future manner of completion (online, mobile, traditional), websites used
  • Practice Profile: Work setting, number of patients seen, number of prescriptions written
  • Digital Interaction with Pharma and Healthcare Companies: Top pharma properties, website features of interest, HCP service portals

About Taking the Pulse® Nurses
Taking the Pulse® Nurses was conducted in Q2 2010 among a nationally representative sample of 1,023 U.S. practicing nurses and physician assistants (PAs) via online survey methodology.

Healthcare and pharmaceutical marketers and other industry stakeholders use Taking the Pulse® Nurses to examine technology, media, channel, and promotional mix strategies as well as to benchmark their performance against industry competitors. In addition to analyzing overall market trends, clients can segment the study to derive statistically relevant insights across more than twenty specialist groups.

For additional product and subscription information, please visit http://www.manhattanresearch.com/ttpnurses.

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a global pharmaceutical and healthcare market research and strategic advisory firm and conducts annual research studies covering eHealth trends among physicians and consumers, including Taking the Pulse®, Taking the Pulse® Nurses, Taking the Pulse® Europe, Taking the Pulse® Asia, Cybercitizen Health®, Cybercitizen Health® Europe, ePharma Consumer®, and ePharma Physician®. Broad consumer and physician research is complemented by targeted analysis for over 100 consumer therapeutic segments and physician specialist segments. For more information, please visit http://www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.decisionresourcesinc.com.

Most Popular Now

Pfizer and Lilly announce top-line results from lo…

Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) announced top-line results from a Phase 3 study evaluating tanezumab 2.5 mg and 5 mg. The objective of the stu...

Bristol-Myers Squibb reports first quarter financi…

Bristol-Myers Squibb Company (NYSE:BMY) today reported results for the first quarter of 2019 which were highlighted by strong demand for Opdivo (nivolumab) and Eliquis (a...

Walnuts may help lower blood pressure for those at…

When combined with a diet low in saturated fats, eating walnuts may help lower blood pressure in people at risk for cardiovascular disease, according to a new Penn State ...

Amgen ignites a social fitness movement to support…

Amgen (NASDAQ:AMGN) launched the Breakaway Challenge initiative, a national social fitness program to motivate individuals to take action in their health and to support t...

Comprehensive tumor profiling promises new therape…

The WINTHER trial, NCT01856296, led by investigators from Vall d'Hebron Institute of Oncology - VHIO (Spain), Chaim Sheba Medical Center (Israel) (Raanan Berger), Gustave...

AstraZeneca starts artificial intelligence collabo…

AstraZeneca and BenevolentAI today began a long-term collaboration to use artificial intelligence (AI) and machine learning for the discovery and development of new treat...

Possible link between autism and antidepressants u…

An international team led by Duke-NUS Medical School has found a potential link between autistic-like behaviour in adult mice and exposure to a common antidepressant in t...

Chemotherapy or not?

Case Western Reserve University researchers and partners, including a collaborator at Cleveland Clinic, are pushing the boundaries of how "smart" diagnostic-imaging machi...

Researchers define Alzheimer's-like brain disorder

A brain disorder that mimics symptoms of Alzheimer's disease has been defined with recommended diagnostic criteria and guidelines for advancing future research on the con...

Drugs to prevent stroke and dementia show promise …

Treatments that prevent recurrence of types of stroke and dementia caused by damage to small blood vessels in the brain have moved a step closer, following a small study...

Amgen and Syapse enter precision medicine collabor…

Amgen (NASDAQ:AMGN), a world leader in biotechnology, and Syapse, a company powering precision medicine insights through its global provider network, announced a precisio...

Personalizing precision medicine with combination …

Precision oncology often relies on treating patients with a single, molecularly matched therapy that targets one mutation in their tumor. In a report, published online in...